HCA Healthcare, Inc. $HCA Shares Sold by Kiltearn Partners LLP

Kiltearn Partners LLP decreased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 39,500 shares of the company’s stock after selling 3,200 shares during the period. HCA Healthcare comprises approximately 3.0% of Kiltearn Partners LLP’s holdings, making the stock its 11th biggest holding. Kiltearn Partners LLP’s holdings in HCA Healthcare were worth $15,132,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Quadrant Capital Group LLC lifted its position in shares of HCA Healthcare by 1.6% during the second quarter. Quadrant Capital Group LLC now owns 6,261 shares of the company’s stock worth $2,399,000 after purchasing an additional 97 shares during the last quarter. Vinva Investment Management Ltd increased its stake in shares of HCA Healthcare by 28.7% in the second quarter. Vinva Investment Management Ltd now owns 12,754 shares of the company’s stock valued at $4,838,000 after purchasing an additional 2,845 shares during the period. Employees Retirement System of Texas acquired a new position in HCA Healthcare during the 2nd quarter valued at about $590,000. Choreo LLC boosted its stake in HCA Healthcare by 6.6% during the 2nd quarter. Choreo LLC now owns 5,466 shares of the company’s stock valued at $2,094,000 after purchasing an additional 339 shares in the last quarter. Finally, Rhenman & Partners Asset Management AB grew its holdings in HCA Healthcare by 77.5% during the second quarter. Rhenman & Partners Asset Management AB now owns 29,778 shares of the company’s stock worth $11,408,000 after acquiring an additional 13,000 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several recent research reports. The Goldman Sachs Group lifted their price target on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Barclays increased their price objective on HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Robert W. Baird increased their price target on HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a report on Thursday, August 14th. Bank of America lifted their price objective on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a research note on Monday, October 27th. Finally, Mizuho lifted their target price on HCA Healthcare from $475.00 to $505.00 and gave the stock an “outperform” rating in a research report on Monday, October 27th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and nine have given a Hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Trading Down 0.2%

Shares of NYSE HCA opened at $514.67 on Thursday. The company has a market cap of $117.44 billion, a PE ratio of 19.89, a P/E/G ratio of 1.38 and a beta of 1.41. The company has a 50-day moving average of $447.58 and a two-hundred day moving average of $404.31. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the previous year, the company posted $4.90 earnings per share. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.13%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.